Literature DB >> 868833

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

H O Conn.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 868833     DOI： 10.1007/bf01072510

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


× No keyword cloud information.
  15 in total

1.  Comparative efficiency of some tests of cerebral damage.

Authors:  M KORMAN; S BLUMBERG
Journal:  J Consult Psychol       Date:  1963-08

2.  Pathogenesis and treatment of hepatic failure.

Authors:  T C CHALMERS
Journal:  N Engl J Med       Date:  1960-07-07       Impact factor: 91.245

3.  Trial making test as a screening device for the detection of brain damage.

Authors:  E C BROWN; A CASEY; R I FISCH; C NEURINGER
Journal:  J Consult Psychol       Date:  1958-12

4.  Differential effects of lateralized brain lesions on the trail making test.

Authors:  R M REITAN; E L TARSHES
Journal:  J Nerv Ment Dis       Date:  1959-09       Impact factor: 2.254

5.  The relation of the Archimedes spiral aftereffect and the trail making test to brain damage in children.

Authors:  A DAVIDS; L GOLDENBERG; M W LAUFER
Journal:  J Consult Psychol       Date:  1957-10

6.  Relationship of glutamic acid and blood ammonia to hepatic coma.

Authors:  R W ALEXANDER; E BERMAN; D C BALFOUR
Journal:  Gastroenterology       Date:  1955-11       Impact factor: 22.682

7.  Psychiatric aspects of liver disease.

Authors:  E A DAVIDSON; W H SUMMERSKILL
Journal:  Postgrad Med J       Date:  1956-10       Impact factor: 2.401

8.  The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.

Authors:  G B PHILLIPS; R SCHWARTZ; G J GABUZDA; C S DAVIDSON
Journal:  N Engl J Med       Date:  1952-08-14       Impact factor: 91.245

9.  Lactulose in the treatment of acute and chronic hepatic encephalopathy.

Authors:  W P Fung; O T Khoo
Journal:  Singapore Med J       Date:  1971-06       Impact factor: 1.858

10.  Four common tests of brain damage compared.

Authors:  R H Loiselle; K M Young; M M McDonald
Journal:  Psychiatr Commun       Date:  1968
View more
  66 in total

Review 1.  Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.

Authors:  T Gerber; H Schomerus
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Psychiatric aspects of portal-systemic encephalopathy.

Authors:  J Wiltfang; W Nolte; K Weissenborn; J Kornhuber; E Rüther
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

3.  Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil.

Authors:  E A Jones; V I Giger-Mateeva; D Reits; F C Riemslag; B Liberov; H Spekrijse
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

4.  An attempt to decrease ammonia levels after portacaval anastomosis in dogs: hepatic periarterial neurectomy.

Authors:  Sezai Yilmaz; Vedat Kirimlioglu; Daniel Katz; Kayhan Basak; Mehmet Caglikulekci; Cuneyt Kayaalp; Bulent Yildirim; Musa Akoglu
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

5.  Breath ammonia testing for diagnosis of hepatic encephalopathy.

Authors:  Suja DuBois; Sue Eng; Renuka Bhattacharya; Steve Rulyak; Todd Hubbard; David Putnam; David J Kearney
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

6.  Effects of L-carnitine in patients with hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Giovanni Pistone; Rampello Elvira; Carmelo Leotta; Linda Scarpello; Rampello Liborio
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

7.  Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.

Authors:  Carina Centerholt; Marianne Ekblom; Tomas Odergren; Olof Borgå; Gabriela Popescu; Karl-Heinz Molz; Andrea Couturier; Angelika Weil
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

8.  Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors:  H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

9.  Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments.

Authors:  Paul J Thuluvath; Anantha Nuthalapati; Jennifer Price; Anurag Maheshwari
Journal:  J Clin Exp Hepatol       Date:  2015-10-03

10.  Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.

Authors:  P L Lanthier; M Y Morgan
Journal:  Gut       Date:  1985-04       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.